iSpecimen Inc.
ISPC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $107 | $713 | $1,058 | $1,476 |
| % Growth | -85.1% | -32.6% | -28.3% | – |
| Cost of Goods Sold | $205 | $444 | $657 | $1,324 |
| Gross Profit | -$98 | $269 | $400 | $151 |
| % Margin | -91.9% | 37.7% | 37.8% | 10.3% |
| R&D Expenses | $0 | $536 | $545 | $952 |
| G&A Expenses | $864 | $948 | $759 | $3,651 |
| SG&A Expenses | $2,005 | $1,207 | $1,106 | $6,216 |
| Sales & Mktg Exp. | $1,141 | $258 | $347 | $2,565 |
| Other Operating Expenses | $727 | $347 | $387 | -$1,176 |
| Operating Expenses | $2,732 | $2,090 | $2,039 | $5,992 |
| Operating Income | -$2,830 | -$1,821 | -$1,638 | -$5,840 |
| % Margin | -2,655.2% | -255.4% | -154.9% | -395.8% |
| Other Income/Exp. Net | $50 | $774 | -$20 | -$206 |
| Pre-Tax Income | -$2,781 | -$1,047 | -$1,658 | -$6,047 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2,781 | -$1,047 | -$1,658 | -$6,047 |
| % Margin | -2,608.7% | -146.9% | -156.8% | -409.8% |
| EPS | -0.48 | -0.42 | -2.33 | -8.51 |
| % Growth | -14.3% | 82% | 72.6% | – |
| EPS Diluted | -0.48 | -0.42 | -2.33 | -8.51 |
| Weighted Avg Shares Out | 5,840 | 2,497 | 711 | 711 |
| Weighted Avg Shares Out Dil | 5,840 | 2,497 | 711 | 711 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $10 | $3 | $3 |
| Interest Expense | $0 | $0 | $20 | $204 |
| Depreciation & Amortization | $423 | $433 | $433 | $548 |
| EBITDA | -$2,357 | -$615 | -$1,205 | -$5,295 |
| % Margin | -2,211.4% | -86.2% | -114% | -358.9% |